Soleno Therapeutics Inc.

News & Events

Press Releases

In The Media

1. Soleno Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 7, 2025, at 4:30 PM ET

   GlobeNewswire APR 23, 2025 7:00 AM EDT
   REDWOOD CITY, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Solen...
   READ ARTICLE

2. Soleno Therapeutics Announces VYKAT(TM) XR Launch

   GlobeNewswire APR 14, 2025 7:00 AM EDT
   REDWOOD CITY, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASD...
   READ ARTICLE

3. Soleno Therapeutics Announces U.S. FDA Approval of VYKATTM XR to Treat Hyperphagia in Prader-Willi Syndrome

   GlobeNewswire MAR 26, 2025 5:15 PM EDT
   First approved therapy to address hyperphagia in individuals with Prader-Willi syndrome M...
   READ ARTICLE

4. Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results

   GlobeNewswire FEB 27, 2025 4:05 PM EST
   REDWOOD CITY, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDA...
   READ ARTICLE

5. Soleno Therapeutics to Participate in Upcoming February Investor Conferences

   GlobeNewswire JAN 29, 2025 4:05 PM EST
   REDWOOD CITY, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno...
   READ ARTICLE

6. Soleno Therapeutics Enters Into $200 Million Debt Financing with Oxford Finance LLC

   GlobeNewswire DEC 17, 2024 4:05 PM EST
   REDWOOD CITY, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDA...
   READ ARTICLE

7. Soleno Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference

   GlobeNewswire NOV 27, 2024 8:00 AM EST
   REDWOOD CITY, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“S...
   READ ARTICLE

8. Soleno Therapeutics Announces FDA Extension of Review Period for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome

   GlobeNewswire NOV 26, 2024 8:30 AM EST
   REDWOOD CITY, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno...
   READ ARTICLE

9. Soleno Therapeutics Announces Oral Presentations featuring Diazoxide Choline Extended-Release (DCCR) Tablets in Prader-Willi Syndrome at ESPE 2024

   GlobeNewswire NOV 14, 2024 4:05 PM EST
   REDWOOD CITY, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno...
   READ ARTICLE

10. Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

    GlobeNewswire NOV 6, 2024 4:05 PM EST
    REDWOOD CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDA...
    READ ARTICLE